Purespring Therapeutics raises £80/$105 million in a Series B …
London – 9 October 2024 – Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series B …
2 days from now
London – 9 October 2024 – Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …
purespringtx.com
OFF
Purespring Therapeutics Raised A $105M Series B Earlier This Month …
2 days from now
Oct 24, 2024 · Purespring Therapeutics raised a $105M series B earlier this month to advance AAV gene therapies for kidney diseases, including both monogenic and non-monogenic …
biotechtv.com
OFF
Purespring Bottles Up $105M Series B For Kidney Gene Therapy
2 days from now
Oct 9, 2024 · London-based biotech Purespring Therapeutics plans to bring their kidney-tweaking gene therapy to the clinic with the help of a new £80 million (about $105 million) pool of series …
fiercebiotech.com
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series
2 days from now
London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …
globenewswire.com
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series B …
2 days from now
London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …
biospace.com
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series B …
2 days from now
Oct 9, 2024 · Funds raised will support Purespring in advancing its AAV pipeline of gene therapy programmes to treat kidney disease, including its lead programme targeting IgA Nephropathy …
businessupturn.com
OFF
Purespring Therapeutics Presents New Preclinical Data On Novel …
2 days from now
London – 28 October 2024 – Purespring Therapeutics, ... Purespring recently announced it had raised £80 million ($105 million) in a Series B financing to support the initiation of a Phase I/II …
purespringtx.com
OFF
Purespring Nabs $105M To Take Gene Therapy Into The Clinic As …
2 days from now
Oct 9, 2024 · Purespring Therapeutics has reeled in £80 million ($105 million) to test two gene therapies in humans. The Sofinnova Partners-led Series B, disclosed Wednesday morning, …
bcbn.org
OFF
Purespring Therapeutics Raises £80/$105 Million In Series B …
2 days from now
London, 7 October, 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised £80/$105 …
forbion.com
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series B …
2 days from now
Oct 9, 2024 · Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised £80/$105 million …
icheme.org
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series B …
2 days from now
London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …
yahoo.com
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series B …
2 days from now
London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …
businessinsider.com
OFF
Gene Therapy Reduces Harmful Protein Levels In Mouse Kidneys
2 days from now
Oct 29, 2024 · London-based Purespring announced that it had bottled a $105 million series B earlier this month, with plans to use the funds for launching a phase 1/2 trial for PS-002.
fiercebiotech.com
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series B …
2 days from now
Oct 9, 2024 · Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in …
tmcnet.com
OFF
Purespring Therapeutics - LinkedIn
2 days from now
𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: Purespring Therapeutics raised a $105M series B earlier this month to advance AAV gene therapies for kidney diseases, including both monogenic and non ...
linkedin.com
FAQs about Purespring Therapeutics raises £80/$105 million in a Series B … Coupon?
Who is purespring Therapeutics?
Does purespring therapeutics have a series B financing?
Does purespring therapeutics have a kidney nephropathy program?
Who is purespring?
Will purespring bring kidney-tweaking gene therapy to the clinic?
Will purespring's Series B round fund IgA nephropathy treatment?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
